Bullboard Post History

by Proboscises

Order by:

T.ONC	What The ONC/Y Insiders Have at Stake This is a collation of some earlier posts of mine showing the incentive the... January 19, 2023
T.ONC	The Impressive Dr. Bernd Seizinger (Director) Bernd Seizinger is an impressive fellow as can be seen from his many... January 12, 2023
T.ONC	FYI - % Ownership By Insiders of ONC/Y if Options Exercised Currently the ONC/Y insiders collectively hold 4,879,808 shares and options. ... January 11, 2023
T.ONC	Unnecessary dilution of shares not in interest of insiders A certain amount of cash is necessary to maintain solvency and a strong... January 10, 2023
T.ONC	RE:RE:$Value to Insiders from a Potential Buyout Yes, I mis-typed. I guess I'm not used to dealing with all those zeros... January 10, 2023
T.ONC	RE:$Value to Insiders from a Potential Buyout Sorry, I gave the buyout number in millions, but it should be in billions. I&... January 10, 2023
T.ONC	$Value to Insiders from a Potential Buyout I created an excel spreadsheet that calculates the value of the ONC/Y... January 10, 2023
T.ONC	SEDI (System for Electronic Disclosures by Insiders) SEDI (sedi.ca) is the place to go to find insider disclosures in detail... January 8, 2023
T.ONC	RE:RE:RE:RE:Just the facts …need to be understood Having multiple parties interested in ONC/Y takes care of getting a... December 29, 2022
T.ONC	RE:ONCY's pelareorep upregulates PD-(L)1 / PD-L2 Thanks to Noteable for highlighting this impressive trial conducted by... December 21, 2022
T.ONC	RE:Leadership changes at Roche Pharma CEOs pay a price for failed strategies. Billion $ bets that go south... December 12, 2022
T.ONC	Solid Data, Competitive Tension, Timing It’s actually pretty simple. If you want a good price for something it’s... December 11, 2022
T.ONC	Durability, Durability, Durability A dominant theme of the Dec. 8th press release was Pela’s durability of... December 9, 2022
T.ONC	Observations from Adlai Nortye Press Release Observations from the Adlai Nortye Press Release These... December 8, 2022
T.ONC	RE:kol meeting I felt that the doctors who participated in the KOL event had the appropriate... November 14, 2022
T.ONC	Excellent Interview with Matt Coffey - June 2021 Cancer Treatment Goes Viral: Featuring Dr. Matt Coffey I learned much from... November 11, 2022
T.ONC	RE:RE:RE:RE:Using the ATM or You can find the shares outstanding as of Nov. 3, 2022. The numbers are... November 11, 2022
T.ONC	Pela appears to contribute to a DURABLE effect "We were particularly excited to see a partial response deepen into a... November 10, 2022
T.ONC	Here is a quote from Heineman (ONC/Y Chief Medical Officer) "We were particularly excited to see a partial response deepen into a... November 10, 2022
T.ONC	RE:RE:Some thoughts Given what pela can do just in relation to two difficult to treat cancers... November 9, 2022

Become a member today, It's free!

Bullboard Post History

by Proboscises

What The ONC/Y Insiders Have at Stake

The Impressive Dr. Bernd Seizinger (Director)

FYI - % Ownership By Insiders of ONC/Y if Options Exercised

Unnecessary dilution of shares not in interest of insiders

RE:RE:$Value to Insiders from a Potential Buyout

RE:$Value to Insiders from a Potential Buyout

$Value to Insiders from a Potential Buyout

SEDI (System for Electronic Disclosures by Insiders)

RE:RE:RE:RE:Just the facts …need to be understood

RE:ONCY's pelareorep upregulates PD-(L)1 / PD-L2

RE:Leadership changes at Roche

Solid Data, Competitive Tension, Timing

Durability, Durability, Durability

Observations from Adlai Nortye Press Release

RE:kol meeting

Excellent Interview with Matt Coffey - June 2021

RE:RE:RE:RE:Using the ATM or

Pela appears to contribute to a DURABLE effect

Here is a quote from Heineman (ONC/Y Chief Medical Officer)

RE:RE:Some thoughts

Featured Company

Freegold Ventures Limited T.FVL

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Proboscises

Featured Company